Maynard Um
-
-
-
-
-
-
-
Pulse Biosciences plans warrant redemption after stock price trigger
-
-
-
-
-
-
-
Pulse Biosciences shifts focus to cardiac catheter program after AFib study
-
-
-
-
-
-
-
Pulse Biosciences begins thyroid tumor research with MD Anderson Cancer Center
-
-
-
-
-
-
-
Pulse Biosciences, Inc. (PLSE) Reports Q2 Loss of $0.28
-
-
-
-
-
-
-
Pulse Biosciences (PLSE) Appoints Paul LaViolette as Chief Executive Officer
-
-
-
-
-
-
447,926 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

